Kelfred Holdings Limited (1134.HK)

Healthcare | Medical Instruments Supplies
Latest reporting period: 2026-04-08

Latest Quarter

2026-04-08

Revenue

$243M

Net Income

-$4.7M

Operating Margin

-0.8%

Free Cash Flow

$12.5M

Debt / Assets

47.5%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Kelfred Holdings Limited (1134.HK).
Income Statement (Quarterly) 2026-04-08 2025-12-31 2025-06-30 2025-03-31
Revenue 242,524,000 257,729,000 242,524,000 121,262,000
Cost of Revenue 211,313,000 229,630,000 211,313,000 105,656,500
Gross Profit 31,211,000 28,099,000 31,211,000 15,605,500
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 34,808,000 42,535,000 34,808,000 17,404,000
Operating Expenses 33,082,000 42,425,000 33,082,000 16,541,000
Operating Income -1,871,000 -14,326,000 -1,871,000 -935,500
Interest Expense 0 1,093,000 1,543,000 0
Income Before Tax -3,420,000 -10,315,000 -3,420,000 -1,710,000
Income Tax Expense 1,297,000 134,000 1,297,000 648,500
Net Income -4,717,000 -10,449,000 -4,717,000 -2,358,500
Per Share
EPS -0.01 -0.02 -0.01 0.00
EPS Diluted 0.00 0.00 0.00 0.00